11.04.2011 • Newscounterfeit drugsEli LillyAstraZeneca

British Man Jailed After Record Fake Medicine Bust

A British man was jailed for eight years on Friday for his role in supplying more than 2 million doses of fake medicines in the most serious known case of counterfeit drugs getting into the European supply chain.

Faking prescription drugs is a lucrative and growing criminal business and Peter Gillespie, 64, was involved in a global network stretching from China to Belgium and Mauritius to supply drugs and launder money, a British court heard.

Investigators from Britain's medicines watchdog said the case was particularly alarming given the serious conditions for which the medicines were used - treating schizophrenia and heart disease and prostate cancer.

A total of 25,000 packs containing 700,000 fake doses of Eli Lilly Zyprexa, Sanofi-Aventis's Plavix and AstraZeneca's Casodex reached pharmacies and patients in care centers, hospitals and at home across Britain in 2007.

A further 47,000 packs were either seized by the Medicines and Healthcare products Regulatory Agency (MHRA) from a warehouse or recalled from the supply chain.

Four other men were acquitted in the case, the MHRA said in a statement.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.